Antisocial Personality Disorder
9
0
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
11%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Resettled Refugee Families for Healing
Illness Management and Recovery- a Cluster Randomized Controlled Trial Within a Forensic Mental Inpatient Setting
Justice-Involved Veterans and Moral Reconation Therapy
Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy
Positive Psychotheraphy and Antisocial Personality Disorder: Crime, Aggression, Anger
Adapting Dialectical Behavior Therapy for the Treatment of Criminal Offenders With Antisocial Personality Disorder
Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
Mental Health Related to School Dropout in Luxembourg
Antisocial Behavior: Passing From Parent to Child to Grandchild